An active ingredient in cough medicines since 1979 has shown promise as a treatment for neuropsychiatric symptoms in ...

A recent phase 2 clinical trial reveals that Ambroxol, a common cough medicine, shows promise in stabilizing psychiatric ...

Parkinson's disease affects approximately 10 million people worldwide. It typically begins asymmetrically, initially ...

Ambroxol, a cough medication, may help stabilize the neuropsychiatric symptoms of Parkinson's disease dementia, a new study ...

The findings of two recent studies give hope that the disease could one day be reversed in humans—but experts warn that this ...

Parkinson's disease often begins asymmetrically, affecting either the right or left side of the body first. Researchers from ...

Parkinson’s disease often starts on one side of the body, and new research shows this asymmetry influences how non-motor symptoms progress.

A safe and affordable treatment to slow the advancement of Parkinson's dementia has emerged – in the form of a commonly ...

Parkinson's disease occurs when brain cells that produce an important hormone called dopamine begin to die off or become ...

Ambroxol, long used for coughs in Europe, stabilized symptoms and brain-damage markers in Parkinson’s dementia patients over ...